These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34246582)

  • 1. Physical function before and after initial treatment among older adults with localized or regional stage prostate cancer.
    Qian J; Li C; Truong CB
    J Geriatr Oncol; 2022 Jan; 13(1):104-107. PubMed ID: 34246582
    [No Abstract]   [Full Text] [Related]  

  • 2. Managing prostate cancer. Part I: Localized disease.
    Edelstein RA; Babayan RK
    Hosp Pract (Off Ed); 1993 Apr; 28(4):61-4, 68-70, 75-8. PubMed ID: 7681843
    [No Abstract]   [Full Text] [Related]  

  • 3. Case records of the Massachusetts General Hospital. Case 15-2008. A 55-year-old man with an elevated prostate-specific antigen level and early-stage prostate cancer.
    Barry MJ; Kaufman DS; Wu CL
    N Engl J Med; 2008 May; 358(20):2161-8. PubMed ID: 18480209
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer.
    Partin AW; Walsh PC
    J Urol; 1994 Jul; 152(1):172-3. PubMed ID: 7515450
    [No Abstract]   [Full Text] [Related]  

  • 5. Re: The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer.
    Roach M
    J Urol; 1993 Dec; 150(6):1923-4. PubMed ID: 7693984
    [No Abstract]   [Full Text] [Related]  

  • 6. [How to treat a localized prostate cancer: irradiation, surgery or watchful waiting?].
    Zellweger T; Gasser T
    Praxis (Bern 1994); 2005 Aug; 94(34):1307-8. PubMed ID: 16170999
    [No Abstract]   [Full Text] [Related]  

  • 7. The management of localized prostate cancer.
    Clarke NW
    Br J Hosp Med; 1996 Mar 6-19; 55(5):232-3. PubMed ID: 8777510
    [No Abstract]   [Full Text] [Related]  

  • 8. Establishment of Korean prostate cancer database by the Korean Urological Oncology Society.
    Ahn H; Kim HJ; Jeon SS; Kwak C; Sung GT; Kwon TG; Park JY; Paick SH
    Investig Clin Urol; 2017 Nov; 58(6):434-439. PubMed ID: 29124243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer: a multi-institutional update.
    Walsh PC
    J Urol; 1997 Oct; 158(4):1618-9. PubMed ID: 9302186
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of stage A1 prostate cancer: the case for treatment.
    Bahnson RR
    Semin Urol; 1993 May; 11(2):54-7. PubMed ID: 7689739
    [No Abstract]   [Full Text] [Related]  

  • 11. Adjuvant therapy for pathologic stage C prostate cancer: a casualty of the PSA revolution?
    Anscher MS
    Int J Radiat Oncol Biol Phys; 1996 Feb; 34(3):745-7. PubMed ID: 8621301
    [No Abstract]   [Full Text] [Related]  

  • 12. Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia.
    Partin AW; Carter HB; Chan DW; Epstein JI; Oesterling JE; Rock RC; Weber JP; Walsh PC
    J Urol; 1990 Apr; 143(4):747-52. PubMed ID: 1690309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Cancer Specific Mortality with Surgery versus Radiation as Primary Therapy for Localized High Grade Prostate Cancer in Men Younger Than 60 Years.
    Huang H; Muscatelli S; Naslund M; Badiyan SN; Kaiser A; Siddiqui MM
    J Urol; 2019 Jan; 201(1):120-128. PubMed ID: 30059685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate cancer.
    Middleton RG
    J Urol; 1994 Mar; 151(3):655. PubMed ID: 7508524
    [No Abstract]   [Full Text] [Related]  

  • 15. Editorial comment on: Analysis of T1c prostate cancers treated at very low prostate-specific antigen levels.
    Eggener S
    Eur Urol; 2009 Mar; 55(3):616. PubMed ID: 18639973
    [No Abstract]   [Full Text] [Related]  

  • 16. [Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer--a multi-institutional update].
    Graefen M
    Aktuelle Urol; 2004 Sep; 35(5):377-8. PubMed ID: 15384003
    [No Abstract]   [Full Text] [Related]  

  • 17. Prostate cancer update.
    Rosenberg J; Small EJ
    Curr Opin Oncol; 2003 May; 15(3):217-21. PubMed ID: 12778015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Editorial comment on: predictive factors for progression in patients with clinical stage T1a prostate cancer in the PSA era.
    Scattoni V
    Eur Urol; 2008 Feb; 53(2):361. PubMed ID: 17611014
    [No Abstract]   [Full Text] [Related]  

  • 19. Editorial comment on: predictive factors for progression in patients with clinical stage T1a prostate cancer in the PSA era.
    Joniau S
    Eur Urol; 2008 Feb; 53(2):362. PubMed ID: 17611018
    [No Abstract]   [Full Text] [Related]  

  • 20. Expectant management as an option for men with stage T1c prostate cancer: a preliminary study.
    Mohler JL; Williams BT; Freeman JA
    World J Urol; 1997; 15(6):364-8. PubMed ID: 9436286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.